Alexis Álvarez Ramírez

Alexis Álvarez Ramírez

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
José Alberto Peña Flores PortilloJosé Alberto Peña Flores Portillo
José Alberto Peña Flores Portillo
MBMercedes Bermúdez
Mercedes Bermúdez
RRRosalío Ramos-Payán
Rosalío Ramos-Payán
CVCarlos E. Villegas-Mercado
Carlos E. Villegas-Mercado
USUriel Soto-Barreras
Uriel Soto-Barreras
ABAndrés A. Barraza-Gómez
Andrés A. Barraza-Gómez
Head and neck squamous cell carcinoma (HNSCC) originates in the squamous cell lining the mucosal surfaces of the head and neck region, including the oral cavity, nasopharynx, tonsils, oropharynx, larynx, and hypopharynx. The heterogeneity, anatomical, and functional characteristics of the patient make the HNSCC a complex and difficult-to-treat disease, leading to a poor survival rate and a decreased quality of life due to the loss of important physiologic functions and aggressive surgical injury. Alteration of driver-oncogenic and tumor-suppressing lncRNAs has recently been recently in HNSCC to obtain possible biomarkers for diagnostic, prognostic, and therapeutic approaches. This review provides current knowledge about the implication of lncRNAs in drug resistance mechanisms in HNSCC. Chemotherapy resistance is a major therapeutic challenge in HNSCC in which lncRNAs are implicated. Lately, it has been shown that lncRNAs involved in autophagy induced by chemotherapy and epithelial–mesenchymal transition (EMT) can act as mechanisms of resistance to anticancer drugs. Conversely, lncRNAs involved in mesenchymal–epithelial transition (MET) are related to chemosensitivity and inhibition of invasiveness of drug-resistant cells. In this regard, long non-coding RNAs (lncRNAs) play a pivotal role in both processes and are important for cancer detection, progression, diagnosis, therapy response, and prognostic values. As the involvement of more lncRNAs is elucidated in chemoresistance mechanisms, an improvement in diagnostic and prognostic tools could promote an advance in targeted and specific therapies in precision oncology.

31 January 2023 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
José Alberto Peña Flores PortilloJosé Alberto Peña Flores Portillo
José Alberto Peña Flores Portillo
DEDiego Enríquez-Espinoza
Diego Enríquez-Espinoza
DCDANIELA MUELA CAMPOS
DANIELA MUELA CAMPOS
Alexis Álvarez RamírezAlexis Álvarez Ramírez
Alexis Álvarez Ramírez
ASAngel Sáenz
Angel Sáenz
KGKarla González-Alvarado
Karla González-Alvarado
Cancer is responsible for more than 10 million deaths every year. Metastasis and drug resistance lead to a poor survival rate and are a major therapeutic challenge. Substantial evidence demonstrates that an increasing number of long non-coding RNAs are dysregulated in cancer, including the long intergenic non-coding RNA, regulator of reprogramming (linc-ROR), which mostly exerts its role as an onco-lncRNA acting as a competing endogenous RNA that sequesters micro RNAs. Although the properties of linc-ROR in relation to some cancers have been reviewed in the past, active research appends evidence constantly to a better comprehension of the role of linc-ROR in different stages of cancer. Moreover, the molecular details and some recent papers have been omitted or partially reported, thus the importance of this review aimed to contribute to the up-to-date understanding of linc-ROR and its implication in cancer tumorigenesis, progression, metastasis, and chemoresistance. As the involvement of linc-ROR in cancer is elucidated, an improvement in diagnostic and prognostic tools could promote and advance in targeted and specific therapies in precision oncology.

1 January 2022 in Revista de la Asociación Dental Mexicana
Verified
Journal Article
Closed access
PDF file
Alexis Álvarez RamírezAlexis Álvarez Ramírez
Alexis Álvarez Ramírez
DCDaniela Muela Campos
Daniela Muela Campos
NTNorma Isela Domínguez Torres
Norma Isela Domínguez Torres
MAMartha Milena Corral Apodaca
Martha Milena Corral Apodaca
LCLuis Osbaldo Montes Chavira
Luis Osbaldo Montes Chavira
GBGustavo Gil Reza Bravo
Gustavo Gil Reza Bravo